600511.SS
600511.SS
CNE000001D56
CHINA NATIONAL MEDICINES CORP
Loading chart...

Company Profile

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co. Ltd.

Related stocks

0874.HK
0874.HK • China
BAIYUNSHAN PH
13.21 HKD
2.74B USD 1Y -27.9%
600998.SS
600998.SS • China
JOINTOWN PHARMACEUTICAL GROUP C
5.08 CNY
3.83B USD 1Y +3.3%
600056.SS
600056.SS • China
CHINA MEHECO GROUP CO LTD
9.14 CNY
2.05B USD 1Y -19.3%
301015.SZ
301015.SZ • China
BAHEAL MEDICAL
25.94 CNY
2.04B USD 1Y -4.5%
000028.SZ
000028.SZ • China
SINOPHARM ACCORD
19.96 CNY
1.83B USD 1Y -13.1%
600332.SS
600332.SS • China
GUANGZHOU BAIYUNSHAN PHARMACEUT
19.97 CNY
4.86B USD 1Y -22.1%
2607.HK
2607.HK • China
SH PHARMA
11.03 HKD
5.21B USD 1Y -11.4%
000950.SZ
000950.SZ • China
CQP
5.34 CNY
1.37B USD 1Y +3.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
28.0% p.a.
Max Drawdown (5Y)
-40.9%
Sharpe Ratio (5Y)
-0.17
Beta Factor
0.13
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -59.7% in the extended horizon.
ende